
    
      This trial is a single centre, open-label, randomised 4 period cross-over trial, comparing
      the pk and pd profiles of IAsp, BIAsp 50, BIAsp 70 and Fast-acting Human Insulin after a
      standard test meal in subjects with type 1 diabetes. The profiles will be derived over a
      12-hour period after subcutaneous injection in the abdominal region with a single dose of
      IAsp, BIAsp 50, BIAsp 70 or Fast-acting Human Insulin at a test meal. The trial consists of a
      screening period of 4-21 days and 4 treatment visits.
    
  